![(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8...](https://static.cymitquimica.com/products/3D/img/QAC90820.png "Haga clic para ampliar")
(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
CAS: 1265908-20-0
Ref. 3D-QAC90820
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- Ergosta-4,22-diene-3,6-dione, 8,14-epoxy-, (14β,22E)-
- (14β,22E)-8,14-Epoxyergosta-4,22-diene-3,6-dione
(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione is a potent inhibitor of protein kinases that has been shown to have medicinal properties in the treatment of cancer cells and tumors. This compound inhibits the activity of several key proteins involved in the cell cycle and has been found to induce apoptosis in both Chinese hamster ovary cells and human cancer cell lines. Additionally, this compound has demonstrated anticancer activity in animal models and is excreted in urine following administration. The inhibition of protein kinases by (1S,3R,6R,7R,10R,
Propiedades químicas
Consulta técnica sobre: 3D-QAC90820 (1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
